GRAIL, Inc.
GRALNasdaqCIK 1699031HealthcareFiscal year ends Dec 31
Reports and events: 41 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0620:11 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-054307 |
| 2026-08-0520:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-053341 |
| 2026-06-2220:50 ET | 8-K | 5.07 Shareholder vote results | 0001628280-26-044693 |
| 2026-06-0120:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-039461 |
| 2026-05-0720:09 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628280-26-032090 |
| 2026-05-0520:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-030495 |
| 2026-04-2820:18 ET | DEF 14A | Proxy statementPeriod 2026-06-18 | 0001628280-26-027946 |
| 2026-03-1220:40 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001628280-26-017319 |
| 2026-02-1921:18 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001699031-26-000009 |
| 2026-01-1215:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-001786 |
| 2025-11-1411:19 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-052184 |
| 2025-11-1321:04 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001699031-25-000193 |
| 2025-11-1221:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001699031-25-000189 |
| 2025-10-2020:21 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001628280-25-045532 |
| 2025-10-1621:02 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-045239 |
| 2025-09-1801:35 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001699031-25-000180 |
| 2025-08-1320:07 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001699031-25-000166 |
| 2025-08-1220:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001699031-25-000162 |
| 2025-05-3021:05 ET | 8-K | 5.07 Shareholder vote results | 0001699031-25-000122 |
| 2025-05-1620:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001699031-25-000120 |
| 2025-05-1420:11 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001699031-25-000114 |
| 2025-05-1320:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001699031-25-000110 |
| 2025-04-1515:09 ET | DEF 14A | Proxy statementPeriod 2025-05-29 | 0001699031-25-000075 |
| 2025-04-1520:06 ET | DEF 14A | Proxy statementPeriod 2025-05-29 | 0001699031-25-000073 |
| 2025-03-0521:29 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001699031-25-000041 |
| 2025-02-2021:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001699031-25-000016 |
| 2025-01-1517:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-001580 |
| 2024-11-1321:12 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001628280-24-047606 |
| 2024-11-1221:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-047100 |
| 2024-10-2221:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0001628280-24-043305 |
| 2024-08-1320:59 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001628280-24-036965 |
| 2024-08-1320:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-036944 |
| 2024-08-0620:53 ET | 8-K | 7.01 Regulation FD disclosure | 0001628280-24-035247 |
| 2024-07-0220:49 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-24-030858 |
| 2024-06-2721:05 ET | 8-K | 2.06 Material impairments | 0001628280-24-030355 |
| 2024-06-2421:09 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-24-167037 |
| 2024-06-1221:42 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-159261 |
| 2024-06-0621:52 ET | 8-K/A | 8.01 Other events | 0001193125-24-155278 |
| 2024-06-0321:25 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-153238 |
| 2020-09-1721:16 ET | S-1/A | Registration statement, amended | 0001628280-20-013710 |
| 2020-09-0910:06 ET | S-1 | Registration statement | 0001628279-20-000227 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.